Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct;11(10):1382-1392.
doi: 10.1002/psp4.12853. Epub 2022 Aug 9.

Application of longitudinal item response theory models to modeling Parkinson's disease progression

Affiliations

Application of longitudinal item response theory models to modeling Parkinson's disease progression

Haotian Zou et al. CPT Pharmacometrics Syst Pharmacol. 2022 Oct.

Abstract

The Movement Disorder Society revised version of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) parts 2 and 3 reflect patient-reported functional impact and clinician-reported severity of motor signs of Parkinson's disease (PD), respectively. Total scores are common clinical outcomes but may obscure important time-based changes in items. We aim to analyze longitudinal disease progression based on MDS-UPRDS parts 2 and 3 item-level responses over time and as functions of Hoehn & Yahr (H&Y) stages 1 and 2 for subjects with early PD. The longitudinal item response theory (IRT) modeling is a novel statistical method addressing limitations in traditional linear regression approaches, such as ignoring varying item sensitivities and the sum score balancing out improvements and declines. We utilized a harmonized dataset consisting of six studies with 3573 subjects with early PD and 14,904 visits, and mean follow-up time of 2.5 years (±1.57). We applied both a unidimensional (each part separately) and multidimensional (both parts combined) longitudinal IRT models. We assessed the progression rates for both parts, anchored to baseline H&Y stages 1 and 2. Both the uni- and multidimensional longitudinal IRT models indicate significant worsening time effects in both parts 2 and 3. Baseline H&Y stage 2 was associated with significantly higher baseline severities, but slower progression rates in both parts, as compared with stage 1. Patients with baseline H&Y stage 1 demonstrated slower progression in part 2 severity compared to part 3, whereas patients with baseline H&Y stage 2 progressed faster in part 2 than part 3. The multidimensional model had a superior fit compared to the unidimensional models and it had excellent model performance.

PubMed Disclaimer

Conflict of interest statement

The authors declared no competing interests for this work.

Figures

FIGURE 1
FIGURE 1
LOWESS curves of part 2 (a) and part 3 (b) sum scores based on 3573 subjects and 14,904 visits.
FIGURE 2
FIGURE 2
The estimated rates of progression among subjects with Hoehn & Yahr stage 1 (red color) and stage 2 (blue color) in part 2 severity (a) and part 3 severity (b) from the unidimensional longitudinal IRT models, and in part 2 severity (c) and part 3 severity (d) from the multidimensional longitudinal IRT models. IRT, item response theory.

References

    1. McFarthing K, Rafaloff G, Baptista MAS, Wyse RK, Stott SRW. Parkinson’s disease drug therapies in the clinical trial pipeline: 2021 update. J Parkinsons Dis. 2021;11:891‐903. - PMC - PubMed
    1. Hauser RA. Help cure Parkinson’s disease: please don’t waste the Golden Year. npj Park Dis. 2018;4:1‐2. - PMC - PubMed
    1. Goetz CG, Tilley BC, Shaftman SR, et al. Movement Disorder Society‐sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS‐UPDRS): scale presentation and clinimetric testing results. Mov Disord Off J Mov Disord Soc. 2008;23:2129‐2170. - PubMed
    1. Marek K, Jennings D, Lasch S, et al. The Parkinson progression marker initiative (PPMI). Prog Neurobiol. 2011;95:629‐635. - PMC - PubMed
    1. Malek N, Swallow DM, Grosset KA, et al. Tracking Parkinson’s: study design and baseline patient data. J Parkinsons Dis. 2015;5:947‐959. - PMC - PubMed

Publication types